4.71 (-%)
As of Nov 01, 2024
Source:
We are a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction. With more than one billion smokers globally and over 34 million smokers in the United States alone, smoking remains the leading cause of preventable disease and death, responsible for more than eight million deaths annually worldwide. Our primary focus is to address this global epidemic.
Country | United States |
Headquarters | seattle, washington |
Phone Number | 425-686-1500 |
Industry | manufacturing |
CEO | John Bencich |
Website | http://www.achievelifesciences.com |